Irina Barash, M.D., M.S.
Nephrologist, The Rogosin Institute
Research Trials
- A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects with Autosomal Dominant Polycystic Kidney Disease
- A Clinical Trial of Water Therapy for Autosomal Dominant Polycystic Disease
- Autosomal Dominant Polycystic Kidney Disease Somatic Mutation Biorepository
